Results 101 to 110 of about 49,735 (302)
, 2009 The clinical use of intravenous immunoglobulin (IVIg) has expanded beyond its traditional place in the treatment of patients with primary immunodeficiencies.
Hartung, H.-P. +5 more
core +1 more source
Circulating monocyte partitioning and its alteration in hematological chronic neoplasms
Cytometry Part B: Clinical Cytometry, EarlyView.Abstract Circulating monocyte partitioning refers to the relative quantification of the three main monocyte subsets in the peripheral blood, namely classical (cMo), intermediate (iMo), and non‐classical (ncMo) monocytes, as assessed by flow cytometry, a new nomenclature described 15 years ago.
Sihem Tarfi +4 more
wiley +1 more source
PLoS ONE, 2011 Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use in immune modulating therapies such as treatment of immune thrombocytopenic purpura high doses of IVIg are required.
Theresa Guhr +6 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
IVIG protection of Rag mice is HSV1 dose dependent.
, 2015 (A) B6-Rag or (B) 129-Rag mice infected with HSV1 at 10x, 32x or 100x LD50 were treated with either PBS or 4 mg IVIG at 24 h pi and monitored for survival (n = 12–28 mice / treatment group).
Patric S. Lundberg (700990) +7 more
core +1 more source
Cognitive Impairment, Depression and Cerebral Microbleeds in Immune Thrombocytopenia (ITP)
American Journal of Hematology, EarlyView.
Camelia Vladescu +10 more
wiley +1 more source
Cenobamate use in super‐refractory status epilepticus: A report of three cases
Epileptic Disorders, EarlyView.Abstract Objectives Super‐refractory status epilepticus (SRSE) is a neurological emergency with high morbidity and mortality. Cenobamate, a novel antiseizure medication, may be helpful in managing SRSE, but evidence is limited. Methods This retrospective case series reports the use of cenobamate as add‐on therapy in the management of three cases of ...
Marina Romozzi +11 more
wiley +1 more source
IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy
, 2010 The pathogenesis of multifocal motor neuropathy (MMN) has yet to be established. MMN patients often carry anti-GM1 IgM antibodies, suggesting an autoimmune process involving complement.
T. Nakajima +11 more
core +1 more source
Molecular and immunological biomarkers to predict IVIg response [PDF]
, 2015 International audienceSome patients with autoimmune and inflammatory diseases treated with intravenous immunoglobulin G (IVIg) as a first line therapy are refractory. Identification of predictive biomarker(s) to segregate responders and non-responders to
Kaveri, Srini, +3 more
core +1 more source
NMDAR‐antibody encephalitis: Seizure semiology and EEG findings
Epileptic Disorders, EarlyView.Abstract Background N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a ...
Maria Emilia C. Andraus +6 more
wiley +1 more source